Product Information

DEXTROAMP-AMPHET ER 25 MG CAP is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.6123 per EA under NDC 31722018901. Its NADAC has been published 245 times since Mar 16, 2022.

FDA first approved this application on Sep 29, 2021. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

6.25; 6.25; 6.25; 6.25 mg/1; mg/1; mg/1; mg/1

NDC

31722018901

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA214959

FDA Approved

9/29/2021

TE Code

AB1

On Market Since

9/29/2021

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has been published 245 times since Mar 16, 2022, and over the history we have for it it has risen 15.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6123 per EA
All-time high$0.7537 (Mar 12, 2025)
All-time low$0.4173 (May 22, 2024)
52-week high$0.6123
52-week low$0.4895
Median price$0.5633
Average price$0.5809
Largest weekly change+30.3% (Dec 18, 2024)
Weeks tracked245
Tracking sinceMar 16, 2022

Price History

1W

+8.9%

1M

+25.1%

3M

+23.6%

6M

+12.5%

1Y

+11.9%

3Y

+7.8%

5Y

N/A

All

+15.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHET ER 25 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 25 MG CAP, manufactured by Camber Pharmaceuticals Inc., is $0.6123 per EA (NDC 31722018901), effective Nov 18, 2026.

How has the price of DEXTROAMP-AMPHET ER 25 MG CAP changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has risen 15.5%. It has been tracked across 245 weekly CMS publications since Mar 16, 2022.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 25 MG CAP?

Since Mar 16, 2022, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has ranged from a low of $0.4173 (May 22, 2024) to a high of $0.7537 (Mar 12, 2025), with a median of $0.5633 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHET ER 25 MG CAP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHET ER 25 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHET ER 25 MG CAP?

DEXTROAMP-AMPHET ER 25 MG CAP (NDC 31722018901) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.